KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Current Leases (2019 - 2025)

Quest Diagnostics' Current Leases history spans 7 years, with the latest figure at $174.0 million for Q4 2025.

  • For Q4 2025, Current Leases rose 0.58% year-over-year to $174.0 million; the TTM value through Dec 2025 reached $174.0 million, up 0.58%, while the annual FY2025 figure was $174.0 million, 0.58% up from the prior year.
  • Current Leases for Q4 2025 was $174.0 million at Quest Diagnostics, up from $173.0 million in the prior quarter.
  • Across five years, Current Leases topped out at $176.0 million in Q3 2024 and bottomed at $145.0 million in Q2 2021.
  • The 5-year median for Current Leases is $155.0 million (2022), against an average of $158.9 million.
  • The largest annual shift saw Current Leases grew 13.07% in 2024 before it decreased 1.7% in 2025.
  • A 5-year view of Current Leases shows it stood at $151.0 million in 2021, then grew by 1.32% to $153.0 million in 2022, then changed by 0.0% to $153.0 million in 2023, then grew by 13.07% to $173.0 million in 2024, then increased by 0.58% to $174.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Current Leases are $174.0 million (Q4 2025), $173.0 million (Q3 2025), and $171.0 million (Q2 2025).